Prevention of glucocorticoid-induced osteoporosis.

被引:0
|
作者
Yood, RA
Harrold, LR
Fish, L
Cernieux, J
Emani, S
Conboy, E
Gurwitz, JH
机构
来源
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
454
引用
收藏
页码:S142 / S142
页数:1
相关论文
共 50 条
  • [1] Temporal trends in prevention of glucocorticoid-induced osteoporosis.
    Saag, KG
    Gehlbach, SH
    Curtis, JR
    Worley, K
    Youket, TE
    Lange, JL
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S266 - S266
  • [2] Temporal trends in prevention of glucocorticoid-induced osteoporosis.
    Saap, KG
    Gehlbach, SH
    Curtis, JR
    Worley, K
    Youket, TE
    Lange, L
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S455 - S455
  • [3] Glucocorticoid-induced osteoporosis.
    Boulos P.
    Ioannidis G.
    Adachi J.D.
    Current Rheumatology Reports, 2000, 2 (1) : 53 - 61
  • [4] Secondary osteoporoses and glucocorticoid-induced osteoporosis.
    Orcel, P
    Krane, SM
    ANNALES DE MEDECINE INTERNE, 2000, 151 (06): : 497 - 503
  • [5] PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    REID, IR
    SCHOOLER, BA
    STEWART, AW
    JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (06) : 619 - 623
  • [6] PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Carter, Matthew
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : 628 - 628
  • [7] Prevention of glucocorticoid-induced osteoporosis
    van Brussel, M. S.
    Bultink, I. E. M.
    Lems, W. F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (06) : 997 - 1005
  • [8] PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Adachi, J. D.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S154 - S154
  • [9] Consistency of effect of alendronate in glucocorticoid-induced and postmenopausal osteoporosis.
    Ernkey, R
    Saag, K
    Brown, J
    Correa-Rotter, R
    Malice, MP
    Carofano, W
    Dalfotis, A
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S44 - S44
  • [10] Retrospective evaluation of the screening and treatment of glucocorticoid-induced osteoporosis.
    Johnson, CL
    Vu, O
    PHARMACOTHERAPY, 2002, 22 (10): : 1369 - 1370